MedAnnex announced as a finalist for Scotland's Life Sciences Annual Awards, for "Outstanding Skills Development".
MedAnnex attends the Royal Society of Medicine meeting in London, “Lupus: the invisible illness across all ages”.
MedAnnex invited to join the BIA’s Finance and Tax Advisory Committee meeting on life science SME fiscal policy for 2019 and beyond.
MedAnnex attends bioProcessUK conference in our home city of Edinburgh.
MedAnnex chairs patient monitoring panel at Pharma Integrates, London.
MedAnnex attends Life Sciences Scotland conference in Glasgow, “Moving forward together: to 2025 and beyond”.
MedAnnex invited to join the FTAC (Finance and Tax Advisory Committee) of the BIA. Alongside fellow members including AstraZeneca, EY & Biocity Group, we’ll help shape policies to create a supportive financial environment for UK bioscience.
MedAnnex wins the award for Innovation in Autoimmune Disease Treatment at Corporate LiveWire's Healthcare & Life Sciences Awards 2018.
MedAnnex Ltd awarded £423,000 via SMART: SCOTLAND to develop innovative antibody: Click here for more info
Interview stage complete for the MedAnnex/University of Glasgow four-year PhD, "Annexin-A1 as a target for T cell mediated pathology in psoriatic arthritis”. Click here for more info
MedAnnex features in panel discussion at Oxford Global’s Biotech Investment Showcase in London, addressing the challenges of finding and funding innovation in biotechnology.
MedAnnex attends the Scottish Life Sciences awards, as guests of the BIA.
Georgia Leisegang joins MedAnnex from Edinburgh University’s School of Biological Sciences, for a three-month work-based MSc project exploring the role of annexin A1 in oncology.
MedAnnex was heavily featured in a video shown on the big screen at a well-attended Napier University event, thanking employers who have taken on interns.
MedAnnex on the Advisory Board for Pharma Integrates 2018, scheduled for 12 & 13 November in London.
MedAnnex attends BioTrinity 2018. This year’s theme: ‘Next Generation Healthcare’.
The application process is now open for the MedAnnex/University of Glasgow four-year PhD, "Annexin-A1 as a target for T cell mediated pathology in psoriatic arthritis”. Click here for more info
MedAnnex welcomes Prof Carl Goodyear to its Scientific Advisory Board. Carl is Professor of Translational Immunology at Glasgow University’s Institute of Infection, Immunity and Inflammation, and Director of the GLAZgo Discovery Centre.
Medannex features in BioInitium Advisory’s Multiple Sclerosis report, as an innovative company with the potential to advance MS treatments.
Dr Tina Flatau will deliver a showcase presentation on Medannex, as part of BIA’s networking event at BioCity, Glasgow on Thursday 1 March. Free to attend. Click here for more info
Medannex’s Director of Scientific Operations, Dr Fiona Dempsey, joined AstraZeneca’s Rose Maciewicz at Glasgow University, in a discussion with postdocs about careers in industry